• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Aratana Therapeutics, Inc. (PETX)

    -NasdaqGM
    17.49 Up 0.44(2.58%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:17.05
    Open:17.18
    Bid:N/A
    Ask:23.60 x 1600
    1y Target Est:26.42
    Beta:5.808
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:16.99 - 17.54
    52wk Range:9.20 - 25.50
    Volume:192,151
    Avg Vol (3m):289,394
    Market Cap:595.62M
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PETX

    Comparison

    Symbol% ChgMkt Cap
    PETXUp 2.58%595.62M
    ZTSUp 0.82%22.16B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):904.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.37
    Quarterly EPS Est (Dec-14) :-0.35
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-0.83

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, acquisition, development, and commercialization of biopharmaceutical products for cats, dogs, and other companion animals worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback